How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 System

•Adults with T1D used an investigational tubeless Omnipod 5 AID system for 3 months.•Participants saw improvements in diabetes-related psychosocial outcomes with AID.•Even with positive outcomes with prior therapy, improvements were still observed.•Improvements were not consistently associated with any baseline characteristics.•Positive psychosocial outcomes with AID systems support adoption and long-term use.